|
Cleveland BioLabs Reports First Quarter 2015 Financial Results and …
MarketWatch The Company had 4.3 million common shares outstanding at March 31, 2015, assuming the full conversion of convertible preferred stock and the issuance of shares covered by pre-funded warrants issued in the February financing. In addition, the Company … |
